Acquired hemophilia: A critical bleeding syndrome

Haematologica

Volumn 89, Issue 1, 2004, Pages 96-100

  Baudo, Francesco ^a   De Cataldo, Francesco ^a  

^a OSPEDALE NIGUARDA CA GRANDA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; BLOOD CLOTTING FACTOR 8 CONCENTRATE; BLOOD CLOTTING FACTOR 8 INHIBITOR; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DESMOPRESSIN; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; PREDNISONE; RECOMBINANT BLOOD CLOTTING FACTOR 7A; STEROID; VINCRISTINE;

ABDOMINAL PAIN; AGED; ALGORITHM; ANTIDIURESIS; ARTICLE; AUTOIMMUNE DISEASE; BLEEDING; CASE REPORT; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; HEMATOLOGICAL PARAMETERS; HEMATOMA; HEMOPHILIA; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MALE; PARTIAL THROMBOPLASTIN TIME; PREGNANCY; PSOAS MUSCLE; RHEUMATIC POLYMYALGIA; SIDE EFFECT; THROMBOEMBOLISM; ULTRASOUND; VASOMOTOR DISORDER;

AGED; HEMOPHILIA A; HEMORRHAGE; HUMANS; MALE; SYNDROME;

EID: 0842285304     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (64)

1. Green D, Lechner K. A Survey of 215 non-haemophilic patients with inhibitors to factor VIII. Thromb Haemost 1981;45:200-3.
2. Hoyer LW. Factor VIII inhibitors. Curr Opin Hematol 1995;2:365-71.
3. Morrison AE, Ludlam CA. Acquired haemophilia and its treatment. Br J Haematol 1995;89:231-6.
4. Di Bona E, Schiavoni M, Castaman G, Ciavarella N, Rodeghiero F. Acquired hemophilia: experience of two Italian centers with 17 new cases. Haemophilia 1997;3:183-8.
5. Hoyer LW, Gawryl MS, de la Fuente B. Immunological characterization of factor VIII inhibitors. In: Hoyer LW, editor. Factor VIII inhibitors. New York: Liss; 1995. p. 73-85.
6. Lottenberg R, Kentro TB, Kitchens CS. Acquired haemophilia. A natural history study of 16 patients with factor VIII inhibitors receiving little or no therapy. Arch Intern Med 1987;147:1077-81.
7. Shapiro SS, Hultin M. Acquired inhibitors to blood coagulation factors. Sem Thromb Haemost 1975;1:336-85.
8. Bossi P, Cabane J, Ninet J, Dhote R, Hanslik T, Chosidow O, et al. Acquired hemophilia due to factor VIII inhibitors in 34 patients. Am J Med 1998;105:400-8.
9. Baudo F, Mostarda G, De Cataldo F. Acquired factor VIII and factor IX inhibitors: survey of the Italian Haemophilia Centers (AICE). Register of Acquired factor VIII/IX inhibitors. Haematologica, 2003;88 Suppl 12:93-9.
10. Ludlam CA, Morrison AE, Kessler C. Treatment of acquired hemophilia. Semin Hematol 1994;31 Suppl 4:16-9.
11. Kessler CM, Nemes L. Acquired inhibitors to factor VIII. In: "Inhibitors in patients with Haemophilia". Rodriguez-Merchan EC, Lee C, editors. Blackwell Science Ltd. Oxford; 2002. p. 98-112.
12. Ewenstein BM, Putnam KG, Bohn RL. Nonhemophilic inhibitors of coagulation. In: Kitchens CS, Alving BM, Kessler CM, editors. Consultative Hemostasis and Thrombosis. Elsevier Science, WB Saunders Co: Philadelphia; 2002. p. 75-90.
13. Hauser I, Schneider B, Lechner K. Postpartum factor VIII inhibitors. A review of the literature with special reference to the value of steroid and immunosuppressive treatment. Thromb Haemost 1995;73:1-5.
14. Coller BS, Hultin MB, Hoyer LW, Miller F, Dobbs JV, Dosik MH, et al. Normal pregnancy in a patient with prior post-partum factor VIII inhibitor: with observations on pathogenesis and prognosis. Blood 1981;58:619-24.
15. Neihardt B, Bartels O, Hahn B. Hemmkörperhaemophilie A post-partum. Dtsch Med Wochenschr 1985;110:799.
16. Michiels JJ, Hamulyak K, Nieuwenhuis HK, Novakova I, van Vliet HHDM. Acquired haemophilia A in women postpartum: management of bleeding episodes and natural history of the factor VIII inhibitor. Eur J Haematol 1997;59:105-9.
17. Baudo F. Acquired Factor VIII (FVIII) inhibitors in pregnancy: data from the Italian Haemophilia register relevant to clinical practice. Br J Obstet Gynaecol 2003;110:1-4.
18. Solymoss S. Post partum acquired factor VIII inhibitors: results of a survey. Amer J Hematol 1998,59:1-4
19. Hauser I, Leckner K. Solid tumors and FVIII antibodies. Thromb Haemost 1999;82:1005-7.
20. Sallah S, Nguten NP, Abdallah JM, Hanrahan LR. Acquired hemophilia in patients with hematologic malignancies. Arch Pathol Lab Med 2000;124:730-4.
21. Sallah S, Wan JY. Inhibitors against factor VIII in patients with cancer. Cancer 2001;91:1067-74.
22. Cohen AJ, Kessler CM. Acquired inhibitors. In: Lee CA, editor. Haemophilia. Baillière's Clin Hematol 1995;9:31-54.
23. Kessler CM. An introduction to factor VIII inhibitors. The detection and quantitation. Am J Med 1991;91 Suppl 5A:33-6.
24. Blatt PM, White IIGC, McMillan CW, Roberts HR. Treatment of antifactor VIII antibodies. Thromb Haemost 1977;38:514-23.
25. Kasper CK. The therapy of factor VIII inhibitors. Prog Hemost Thromb 1989;9:57-86.
26. nd ed. 1995. p. 113-29.
27. De la Fuente, Panek S, Hoyer LW. The effect of 1-deamino 8 D-arginine vasopressin (DDAVP) in non-haemophilic patient with an acquired type II inhibitor. Br J Haematol 1985;59:127.
28. Naorose-Abidi SM, Bond LR, Chitolie A, Bevan DH. Desmopressin therapy in patients with acquired factor VIII inhibitors. Lancet 1988;1:366.
29. Muhm M, Grois N, Kier P, Stumpflen A, Kyrle P, Pabinger I, et al. 1-Deamino-8-d-arginine vasopressin in the treatment of non-haemophilic patients with acquired factor VIII inhibitor. Haemostasis 1990;20:15.
30. Schwartz RS, Gabriel DA, Aledort LM, Green D, Kessler CM. A prospective study of acquired (autoimmune) factor VIII inhibitors with high-dose intravenous gammaglobulin. Blood 1995;86:797-804.
31. Hay CR, Negrier C, Ludlam CA. The treatment of bleeding in acquired haemophilia with recombinant factor VIIa: a multicenter study. Thromb Haemost 1997;78:1463-7.
32. Arkin S, Cooper HA, Hutter JJ, Miller S, Schmidt HL, Seibel NL, et al. Activated recombinant human coagulation factor VII therapy for intracranial hemorrhage in patients with Haemophilia A or B with inhibitors. Haemostasis 1998;28:93.
33. Scharrer I. Recombinant factor VIIa for patients with inhibitors to factor VIII or IX deficiency. Hemophilia 1999;5:253-9.
34. Baudo F, Gaidano G. Recombinant activated factor VII (rFVIIa) for the treatment of bleeding secondary to acquired factor VIII inhibitor. Blood 2002;11:[Abstract 3877].
35. Lusher JM, Shapiro SS, Palascak JE, Rao AV, Levine PH, Blatt PM. Efficacy of prothrombin complex concentrates in haemophiliacs with antibodies to factor VIII. A multicentre therapeutic trial. N Engl J Med 1980;303:421-5.
36. Turecek PL, Varadi K, Gritsch H et al. Factor Xa and prothrombin: mechanism of action of FEIBA. Vox Sang 1999;77 Suppl 1:72S-9S.
37. White IIGC. Seventeen years' experience with Autoplex/Autoplex T. Evaluation of inpatients with severe haemophilia A and factor VIII inhibitors at a major haemophilia center. Haemophilia 2000;6:508-12.
38. Chavin SI, Siegel DM, Rocco TA, Olson JP. Acute myocardial infarction during treatment with an activated prothrombin complex concentrate in a patient with factor VIII deficiency and a factor VIII inhibitor. Am J Med 1988;85:245-9.
39. Morrison AE, Ludlam CA, Kessler CM. Use of porcine factor VIII in the treatment of patients with acquired hemophilia. Blood 1993;81:1513-20.
40. Gribble J, Garvey MB. Porcine factor VIII provides clinical benefit to patients with high levels of inhibitors to human and porcine factor VIII. Haemophilia 2000;6:482-6.
41. Bona RD, Ribeno M, Klatsky AV, Panek S, Magnifico H, Rickles FR. Continuous infusion of porcine FVIII for the treatment of patients with factor VIII inhibitors. Semin Hematol 1993;Suppl 1:30-2.
42. Kessler CM, Ludlam CA. The treatment of acquired factor VIII inhibitors: worldwide experience with porcine factor VIII concentrates. Semin Hematol 1993;30:22-7.
43. Hay CRM, Bolton-Maggs P. Porcine factor VIIIC in the management of patients with factor VIII inhibitors. Transfus Med Rev 1991;5:145-51.
44. Gatti L, Mannucci PM. Use of porcine factor VIII in the management of seventeen patients with factor VIII antibodies. Thromb Haemost 1984;51:379-84.
45. Gringeri A, Santagostino E, Tradati F. Adverse effects of treatment with porcine FVIII. Thromb Haemost 1991;65:245-7.
46. Morrison AE, Ludlam CA. The use of porcine factor VIII in the treatment of patients with acquire haemophilia: the Unites Kingdom experience. Am J Med 1991;91 Suppl 5a:27S-36S.
47. Nilsson I, Sundqvist S-B, Freiburghaus C. Extracorporeal protein A sepharose and specific affinity chromatography for removal of antibodies. In: Hoyer LW, ed. Factor VIII inhibitors. New York. Alan R. Liss, 1984:225-41.
48. Négrier C, Dechavanne M, Alfonsi F, Tremisi PJ. Successful treatment of acquired factor VIII antibody by extracorpeal immunoadsorption. Acta Haematol 1991;85:107-10.
49. Gjörstrup P, Berntorp E, Larsson L, Nilsson IM. Kinetic aspects of removal of IgG and inhibitors in hemophiliacs using protein A immunoadsorption. Vox Sang 1991;61:244-50.
50. Knöbl P, Derfler K. Extracorporeal immunoadsorption for the treatment of haemophilic patients with inhibitors to factor VIII or IX. Vox Sang 1999;77 Suppl 1:57S-64S.
51. Jansen M, Schmaldienst S, Banyai, Quehenber P, Pabinger I, Derfler K, et al. Treatment of coagulation inhibitors with extracorporeal immunoadsorption (Ig Therasorb). Br J Haematol 2001;112:91-7.
52. Feinstein DI, Green D, Federici AB, Goodnight SH. Diagnosis and management of patients with spontaneously acquired inhibitors of coagulation. ASH Meeting; Haematology. 1999. p. 192-208.
53. Hay CRM, Colvin BT, Ludlam CA, Hill FGH, Preston FE. Recommendations for the treatment of factor VIII inhibitors: from the UK Haemophilia Center Directors' Organisation Inhibitor Working Party. Blood Coagul Fibrinolysis 1996;7:134-8.
54. Hay CRM. Acquired hemophilia. Baillière's Clin Haematol 1998;11:287-303.
55. Rubinger M, Rivard GM, Teitel J, Walker IL. Suggestions for the management of factor VIII inhibitors. Haemophilia 2000;6 Suppl 1:52S-9S.
56. Spero JA, Lewis JH, Hasiba U. Corticosteroid therapy for acquired FVIII: C inhibitors. Br J Haematol 1991;48:636-42.
57. Green D, Rademaker AW, Briet E. A prospective randomized trial of prednisolone and cyclophosphamide in the treatment of patients with factor VIII antibodies. Thromb Haemost 1993;70:753-7.
58. Bussi L, Baudo F, de Cataldo F. Factor VIII concentrate and cyclophosphamide in patients with factor VIII inhibitors. Blood 1974;44:767.
59. Nemes L, Pitlik E. New protocol for immune tolerance induction in acquired hemophilia. Haematologica 2000;85 (Suppl. to 11):64-8.
60. Huth-Kuhne A, Ehrenforth S, Scharrer I, Zimmermann R. A new treatment option for patients with acquired hemophilia A. The modified Malmö-Heidelber protocol. Thromb Haemost 2001;86:3364a [abstract].
61. Hess L, Zeitler H, Unkrig Ch, Nettekoven W, Albert T, Schwaab R, et al. Modified Bonn-Malmö protocol (MBM-P) Haematologica 2003;88 Suppl 12:78-85.
62. Karwal MW, Schlueter AJ, Zenk DW, Davis RT. Treatment of acquired factor VIII deficiency with rituximab. Blood 2001;98:533a[Abstract].
63. Wiestener A, Cho HJ, Asch AS, Michelis MA, Zeller JA, Peerschke EIB et al. Rituximab in the treatment of acquired factor VIII inhibitors. Blood 2002;100:3426-8.
64. Sallah S, Wan JY. Efficacy of 2-chlorodeoxyadenosine in refractory factor VIII inhibitors in persons without hemophilia. Blood 2003;101:943-5.